Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.42 |
| ▸ | TLR4 | O00206 | 1/20 | 0.36 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.36 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.36 |
| ▸ | PTGFR | P43088 | 1/20 | 0.36 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.36 |
| ▸ | SELP | P16109 | 6/20 | 0.36 |
| ▸ | SELL | P14151 | 5/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL374097 | 1.00 | GPR84 (0.42) | GPR84TLR4DAGLATBXA2RPTGFR | |
| SCHEMBL17294503 | 1.00 | GPR84 (0.42) | GPR84TLR4DAGLATBXA2RPTGFR | |
| SCHEMBL14957946 | 1.00 | GPR84 (0.42) | GPR84TLR4DAGLATBXA2RPTGFR | |
| SCHEMBL14332067 | 1.00 | GPR84 (0.42) | GPR84TLR4DAGLATBXA2RPTGFR | |
| SCHEMBL8013415 | 1.00 | GPR84 (0.42) | GPR84TLR4DAGLATBXA2RPTGFR | |
| SCHEMBL10534787 | 1.00 | GPR84 (0.42) | GPR84TLR4DAGLATBXA2RPTGFR | |
| SCHEMBL17001438 | 0.89 | TLR4 (0.34) | GPR84TLR4TBXA2RPTGFRPTGER2 | |
| SCHEMBL5055853 | 0.88 | SELL (0.41) | GPR84TLR4SELPSELL | |
| SCHEMBL8026363 | 0.88 | SELL (0.41) | GPR84TLR4SELPSELL | |
| SCHEMBL9129668 | 0.83 | GPR84 (0.33) | GPR84DAGLATBXA2RPTGFRPTGER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190118017-A1 | RHAMNOLIPID COATED NANOSCALE ZEROVALENT IRON EMULSIONS AND METHOD OF USE THEREOF | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2019-04-25 | — | — | US | claimed |
| WO-2017177336-A1 | RHAMNOLIPID COATED NANOSCALE ZEROVALENT IRON EMULSIONS AND METHOD OF USE THEREOF | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2017-10-19 | — | — | WO | claimed |
| US-20240182513-A1 | SEPARATION OF METAL IONS FROM A SAMPLE USING GLYCOLIPIDS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA | 2024-06-06 | — | — | US | disclosed |
| WO-2023278801-A1 | SEPARATION OF METAL IONS FROM A SAMPLE USING GLYCOLIPIDS | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2023-01-05 | — | — | WO | disclosed |
| US-10801053-B2 | Process for producing a rhamnolipid produced by Pseudomonas or Enterobacter using andiroba or murumuru seed waste | NATURA COSMETICOS S/A (BR) | 2020-10-13 | — | — | US | disclosed |
| US-20200115729-A1 | PROCESS FOR PRODUCING A RHAMNOLIPID PRODUCED BY PSEUDOMONAS OR ENTEROBACTER USING ANDIROBA OR MURUMURU SEED WASTE | INSTITUTO DE PESQUISAS TECNOLOGICAS DO ESTADO DE SAO PAULO S.A. - IPT (BR) | 2020-04-16 | — | — | US | disclosed |
| EP-3569714-A1 | PROCESS FOR PRODUCING A RHAMNOLIPID PRODUCED BY PSEUDOMONAS OR ENTEROBACTER USING ANDIROBA OR MURUMURU SEED WASTE | Natura Cosméticos S.A. (BR) | 2019-11-20 | — | — | EP | disclosed |
| US-10344304-B2 | Materials derived from fermentation-produced rhamnolipids and methods of production | THE UNIVERSITY OF AKRON (US) | 2019-07-09 | — | — | US | disclosed |
| US-20190118017-A1 | RHAMNOLIPID COATED NANOSCALE ZEROVALENT IRON EMULSIONS AND METHOD OF USE THEREOF | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2019-04-25 | — | — | US | disclosed |
| US-9992998-B2 | Rhamnolipid based biopesticides | THE UNIVERSITY OF AKRON (US) | 2018-06-12 | — | — | US | disclosed |
| WO-2017177336-A1 | RHAMNOLIPID COATED NANOSCALE ZEROVALENT IRON EMULSIONS AND METHOD OF USE THEREOF | THE ROYAL INSTITUTION FOR THE ADVANCEMENT OF LEARNING/MCGILL UNIVERSITY (CA) | 2017-10-19 | — | — | WO | disclosed |
| US-20170175151-A1 | NOVEL MATERIALS DERIVED FROM FERMENTATION-PRODUCED RHAMNOLIPIDS AND METHODS OF PRODUCTION | THE UNIVERSITY OF AKRON | 2017-06-22 | — | — | US | disclosed |
| US-9468700-B2 | Wound dressings with enhanced gas permeation and other beneficial properties | THE UNIVERSITY OF AKRON (US) | 2016-10-18 | — | — | US | disclosed |
| US-20140364381-A1 | WOUND DRESSINGS WITH ENHANCED GAS PERMEATION AND OTHER BENEFICIAL PROPERTIES | THE UNIVERSITY OF AKRON | 2014-12-11 | — | — | US | disclosed |
| WO-2010080406-A1 | METHOD FOR TREATING RHINITIS AND SINUSITIS BY RHAMNOLIPIDS | ADREM BIOTECH, INC. (US) | 2010-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240182513-A1 | SEPARATION OF METAL IONS FROM A SAMPLE USING GLYCOLIPIDS | SGMS2, SGMS1, UGCG | GPR84 3741/4885TLR4 4473/4885DAGLA 133/4885 |
| US-10344304-B2 | Materials derived from fermentation-produced rhamnolipids and methods of production | HACL2, COASY, FASN | GPR84 1041/4885TLR4 4041/4885DAGLA 23/4885 |
| US-20170175151-A1 | NOVEL MATERIALS DERIVED FROM FERMENTATION-PRODUCED RHAMNOLIPIDS AND METHODS OF PRODUCTION | HACL2, COASY, FASN | GPR84 968/4885TLR4 3964/4885DAGLA 14/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.